Fractyl Health (GUTS) Total Debt (2023 - 2026)
Fractyl Health's (GUTS) quarterly Total Debt came in at $30.1 million in Q1 2026, up 2.56% YoY from $29.4 million in Q1 2025, and down 1.47% on a QoQ basis from $30.6 million in Q4 2025.
Fractyl Health (GUTS) Total Debt (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Total Debt data on file, last reported at $30.1 million in Q1 2026.
- Quarterly Total Debt rose 2.56% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (up 2.56% YoY) and the FY2025 annual result came in at $30.6 million, up 1.41% from the prior year.
- Total Debt declined to $30.1 million in Q1 2026, from $30.6 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $30.8 million in Q3 2025 to a low of $28.0 million in Q4 2023.
- A 4-year average of $29.6 million and a median of $30.1 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2024 — Total Debt rose 7.76% — and 2025, when it gained 1.41%.
- Tracing GUTS's Total Debt over 4 years: stood at $28.0 million in 2023, then advanced by 7.76% to $30.2 million in 2024, then grew by 1.41% to $30.6 million in 2025, then fell by 1.47% to $30.1 million in 2026.
- The last three Total Debt figures came in at $30.1 million (Q1 2026), $30.6 million (Q4 2025), and $30.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - | 30.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.45 Mn |
| Mar 31, 2026 | 30.14 Mn |
| Dec 31, 2025 | 30.59 Mn |
| Sep 30, 2025 | 30.77 Mn |
| Jun 30, 2025 | 29.99 Mn |
| Mar 31, 2025 | 29.39 Mn |
| Dec 31, 2024 | 30.16 Mn |
| Sep 30, 2024 | 30.32 Mn |
| Jun 30, 2024 | 28.37 Mn |
| Mar 31, 2024 | 28.70 Mn |
| Dec 31, 2023 | 27.99 Mn |